MedTrace Logo

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

NCT06245759 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2024-02-07

No results posted yet for this study

Summary

Based on large sample size studies at home and abroad, the prognosis of patients with non-muscular invasive bladder cancer in different sites undergoing transurethral bladder tumor resection was determined, providing important guidance for subsequent clinical treatment and surgical instrument development.

Conditions

Interventions

OTHER

This was a retrospective study and no patient intervention was performed

This was a retrospective study and no patient intervention was performed

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Ke Chen, MD/PhD · Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06245759 on ClinicalTrials.gov